Alternative Funding Task Force; create from members of the Mississippi Rare Disease Advisory Council.

SB 2757 creates a task force from the Mississippi Rare Disease Advisory Council to study how alternative funding programs (like patient assistance programs or insurance-based discounts) affect access to affordable prescription drugs for patients in Mississippi. The task force must examine these programs' history, business models, impacts on existing patient assistance programs, and effects on coverage across insurance plans, completing its study by December 1, 2025. It will report findings and legislative recommendations to health organizations, the Governor, and relevant legislative committees. This is a procedural bill focused on research, not policy change.